January 14, 2022 @ 10:45 pm | Breaking News, ILMN, Jubak Top 50 Portfolio |
On January 11, Illumina (ILMN) told analysts at the annual JPMorgan Chase healthcare conference to expect 39% sales growth for 2021 when the company reports earnings on February 10. And that analyst earnings and revenue forecasts for 2022 were too low. Sales would...
March 1, 2021 @ 7:47 pm | Breaking News, CTVA, ILMN, Jubak Picks Portfolio, Jubak Top 50 Portfolio, WST |
As of 2 p.m. New York Time today, March 1, the Standard & Poor’s 500 was up 2.57% and the Dow Jones Industrial Average was higher by 2.30%. The NASDAQ Composite had climbed 2.80% and the NASDAQ 100 had gained 2.83%. The small cap Russell 2000 had added...
September 23, 2020 @ 7:39 pm | Breaking News, ILMN, Jubak Picks Portfolio, Jubak Top 50 Portfolio |
With the Standard & Poor’s 500 falling 2.37% at the close and the NASDAQ 100 down 3.16% for the day, shares of Illumina (ILMN) climbed 1.67%. Yesterday and today the selling of Illumina looks to have exhausted itself. The stock traded at $400.74 as recently...
September 17, 2020 @ 7:07 pm | Breaking News, ILMN, Jubak Picks Portfolio, Jubak Top 50 Portfolio |
Shares of Illumina (ILMN) dropped 8.44% today, September 16, on reports by both Reuters and Bloomberg that the genetic sequencing marketing leader is in talks to acquire Grail, a still private startup focused on blood tests for the early detection of cancer. I think...